Is Danone feeling the need for Mead?

Mead Johnson Nutrition: A Danone target?

 Danone shares rose today as rumours strengthened the French dairy giant would sell its medical and paediatric nutrition business (Nutricia), but is the firm streamlining its activities around its core foods businesses or just shifting infant-medical gears?

Media outlets including the Wall Street Journal and The Financial Times reported Danone is in advanced discussions over a potential €3+bn deal for Danone-Nutricia with Illinois-based drug firm Hospira, although previous suitors for the division like Nestlé, Fresenius were not being totally ruled out.

Analysts said Danone, which underperformed in the first half this financial period and has been criticised for losing its innovation edge amid rising raw material costs, slow consumer demand and regulatory upheaval, would use any sales funds to target Mead Johnson Nutrition.

Selling to buy?

Mead may appeal as it is more tightly focused on infant nutrition.

“The question is how Danone would invest the proceeds of a sale,” Patrik Lang from Julius Baer Group told Bloomberg.

“It’s possible a bigger acquisition is imminent – Mead Johnson would be a candidate.”

Mead Johnson Nutrition is estimated to be worth in the vicinity of €14bn and owns infant formula brands such as Enfamil.

Nutricia offerings include Souvenaid (for the elderly) and Nutrini (children).

Danone, which is the world’s largest yoghurt enterprise with mega-brands like Activia and Actimel, was unavailable for comment. Hospira has also not commented on the matter.

Danone Group shares were trading at about €56 today on the Paris stock exchange.

One report suggested Hospira was interested in the deal, in part at least, as it would be able to shift its tax base to France.

Related News

The unauthorised marketing as it appeared in the Tesco mail-out...

Not ‘normal’ enough, ASA tells ‘disappointed’ Danone Nutricia over infant formula claims

If Danone sells Nutricia and buys Mead, it will become the world's 2nd biggest formula player

Danone sets its sights on becoming number one in milk formula as it is rumoured to be selling its medical nutrition business

Dr Paul Clayton: “We can’t afford the burdens of disease we have already so the projected increases lead to bankruptcy.”

Can the rise of medical foods tackle ‘unsustainable’ public healthcare costs?

Emmanuel Faber (right) will succeed Franck Riboud (left) as CEO on October 1, 2014.

Franck Riboud to step down as Danone CEO after 18 years

Mead Johnson Nutrition takeover 'not discussed' by Danone board

Mead Johnson Nutrition takeover 'not discussed' by Danone board

Leave it to nutrition: “This research is significant because there is limited pre-dementia data and pharmaceutical options to treat Alzheimer’s are not available."

Danone omega-3 medical drink shows early Alzheimer’s benefits: RCT

In a keynote speech at World Food Innovate this week, Danone’s Christophe Perthuisot introduced the concept of 'Friday Tinkering' to foster innovation and build a sustainable product pipeline.

Danone ‘tinkers’ with company culture to innovate

Baby Milk Action: “The now taking a view totally contrary to Department of Health guidance notes.”

UK regulator turns ‘contrary’ over infant drink marketing, says campaigner

WPC recall-impacted Nutricia NZ reports 97% profits drop

WPC recall-impacted Nutricia NZ reports 97% profits drop

China cuts number of permitted imported infant formula brands to 94

China cuts number of permitted imported infant formula brands to less than 100

Nutricia India at ‘risk of non-compliance’ with IMS Act: Danone

Nutricia India at ‘risk of non-compliance’ with IMS Act: Danone

Nutricia India bribed doctors to prescribe baby formula: Whistleblower

Nutricia India bribed doctors to prescribe infant formula, whistleblower claims

Hospital table nutrition: Abbott health professional marketing for Ensure Plus targets the elderly

Are food supplements being over-subscribed in UK hospitals? ‘No,’ says government

Related Products

See more related products

Submit a comment

Your comment has been saved

Post a comment

Please note that any information that you supply is protected by our Privacy and Cookie Policy. Access to all documents and request for further information are available to all users at no costs, In order to provide you with this free service, William Reed Business Media SAS does share your information with companies that have content on this site. When you access a document or request further information from this site, your information maybe shared with the owners of that document or information.